• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT

SYNTARA LIMITED - Charts / Financials

52.6% ! 2.7¢
Market Cap $43.94M  !

Syntara Limited is an Australia-based clinical-stage drug development company. The... Syntara Limited is an Australia-based clinical-stage drug development company. The Company is targeting extracellular matrix dysfunction with its amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The Company’s lead candidate SNT-5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its product candidate, SNT-4728, is an inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 11/08/2025 (20 minute delay) ?
Day
Open 5.4¢   Day High 5.4¢   Day Low 2.7¢
Daily Volume 90379318
Bids   Sellers
Number Price Volume   Number Price Volume
21 2.7¢ 6416796   4 2.9¢ 624400

Directors & Senior Management

Mr. Gary Jonathan Phillips Chief Executive Officer, Managing Director, Executive Director
Mr. David Morris Mcgarvey Chief Financial Officer
Dr. Jana Baskar Chief Medical Officer
Mr. Wolfgang G. Jarolimek Head - Drug Discovery
Ms. Kristen Morgan Alliance Management - Head of Medical and Regulatory Affairs
Mr. Cameron Billingsley Company Secretary
Dr. Kathleen Mary Metters Non-Executive Independent Chairman of the Board
Dr. Simon P. Green Non-Executive Director
Mr. Waradana Malitha Hashan De Silva Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.7¢
Change
-0.030(52.6%)
Mkt cap ! $43.94M
Open High Low Value Volume
5.4¢ 5.4¢ 2.7¢ $2.754M 90.37M

Buyers (Bids)

No. Vol. Price($)
21 6416796 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 624400 4
View Market Depth
Last trade - 16.10pm 11/08/2025 (20 minute delay) ?
Last
2.7¢
  Change
-0.030 ( 51.8 %)
Open High Low Volume
5.0¢ 5.0¢ 2.7¢ 29441392
Last updated 15.59pm 11/08/2025 ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.